Close Menu

NEW YORK (360Dx) – Diagnostics firm Quotient said after the close of the market on Tuesday that it has raised $64.6 million in net proceeds from a public offering of its ordinary shares.

The Switzerland-based firm said that it offered 10.6 million shares of its stock at $6.50 per share. The offering's underwriters exercised in full their option to purchase up to almost 1.4 million additional ordinary shares.

Jefferies and Cowen and Company acted as joint book-running managers for the offering.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Apr
29
Sponsored by
Co-Diagnostics

Join Dr. Heather Fehling, Chief Scientific Officer at Clinical Reference Labs (CRL), as she provides some insights regarding the future applications of PCR testing.

May
13
Sponsored by
LGC SeraCare Life Sciences

As we pass the one-year anniversary of both the COVID-19 pandemic and the first Emergency Use Authorized SARS-CoV-2 PCR detection assays, there remains significant opportunity for clinical laboratories to advance testing and support improved patient management.

May
18
Sponsored by
Bio-Rad

This webinar will present the details of a COVID-19 saliva screening program that has been implemented at more than 90 different colleges, universities, private schools, and nursing homes across New York state.